✨ Your Portfolio is fetched and updated from zerodha.
Large

Dr. Reddy's Laboratories Ltd.

DRREDDY

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹1,06,112 Cr.
P/E
18.68

Dr. Reddy's Laboratories Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
1.06 L Cr
PE
PE
18.68
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
16.86
ROCE (%)
ROCE (%)
22.98
Div Yield (%)
Div Yield (%)
0.59
Sales
Sales
33,519 Cr
OPM (%)
OPM (%)
25.42 %
Debt to Equity
Debt to Equity
-
View more
Edit Ratio's
About
Dr. Reddy's Lab is in the Miscellaneous sector with a M.cap of 106112.00 Cr and a PE r… Read more
Low
52W Range
High

Insufficient data

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Dr. Reddy's Laboratories Ltd. Business

Dr. Reddy’s Laboratories Limited, a leading India-based pharmaceutical company, has been serving millions of patients with high quality and innovative medicines since 1986. It offers a wide range of products and services in the pharmaceutical industry.

Dr. Reddy's Lab major competitors are Mankind Pharma, Zydus Lifesciences, Torrent Pharma, Lupin, Cipla, Abbott India, Alkem Laboratories.
Market Cap of Dr. Reddy's Lab is ₹1,05,411 Crs.
While the median market cap of its peers are ₹99,683 Crs.

Dr. Reddy's Lab seems to be less financially stable compared to its competitors.
Altman Z score of Dr. Reddy's Lab is 6.93 and is ranked 7 out of its 8 competitors.

View FAQ's On Shareprice
Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release May Jul Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Sep Dec Mar Jun Sep Dec Sep Dec Mar Jun Mar Jun Sep Dec
Investor Presentation May Jul Mar Jun Mar Jun Sep Mar Jun Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec
Conference Call Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material